Goldman Sachs’s MiNK Therapeutics INKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$16.7K Buy
2024
Q1
$14.2K Sell
2023
Q4
$21.5K Buy
2023
Q3
$19K Buy
2023
Q2
$35.7K Buy